Joseph C. Geagea - 25 Feb 2022 Form 4 Insider Report for CHEVRON CORP (CVX)

Signature
/s/ Rose Z. Pierson, Attorney-in-Fact for Joseph C. Geagea
Issuer symbol
CVX
Transactions as of
25 Feb 2022
Net transactions value
-$1,561,070
Form type
4
Filing time
01 Mar 2022, 17:01:27 UTC
Previous filing
15 Feb 2022
Next filing
06 May 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVX Common Stock Options Exercise $4,658,000 +40,000 +3218% $116.45 41,243 25 Feb 2022 Direct
transaction CVX Common Stock Sale $2,760,000 -20,000 -48% $138.00 21,243 25 Feb 2022 Direct
transaction CVX Common Stock Sale $2,800,000 -20,000 -94% $140.00 1,243 25 Feb 2022 Direct
transaction CVX Common Stock Options Exercise $1,160,000 +10,000 +805% $116.00 11,243 28 Feb 2022 Direct
transaction CVX Common Stock Options Exercise $1,037,100 +10,000 +89% $103.71 21,243 28 Feb 2022 Direct
transaction CVX Common Stock Sale $2,856,170 -20,000 -94% $142.81 1,243 28 Feb 2022 Direct F1
holding CVX Common Stock 25,489 25 Feb 2022 by 401(k) plan
holding CVX Common Stock 2,500 25 Feb 2022 By Geagea Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVX Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -40,000 -100% $0.000000* 0 25 Feb 2022 Common Stock 40,000 $116.45 Direct F2
transaction CVX Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -10,000 -11% $0.000000 80,000 28 Feb 2022 Common Stock 10,000 $116.00 Direct F3
transaction CVX Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -10,000 -6.7% $0.000000 140,000 28 Feb 2022 Common Stock 10,000 $103.71 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $142.80 to $142.87. The price reported above reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 Option granted 1/30/2013. One-third of the shares subject to the option vested on each of the first, second and third anniversaries of the date of grant.
F3 Option granted 1/29/2014. One-third of the shares subject to the option vested on each of the first, second and third anniversaries of the date of grant.
F4 Option granted 1/28/2015. One-third of the shares subject to the option vested on each of the first, second and third anniversaries of the date of grant.